Bill Text: TX HB1313 | 2023-2024 | 88th Legislature | Introduced
Bill Title: Relating to a study on the side effects, adverse reactions, including death, and the effectiveness of vaccines against the SARS-CoV-2 virus (COVID-19) or its variants.
Spectrum: Partisan Bill (Republican 15-0)
Status: (Introduced - Dead) 2023-03-20 - Left pending in committee [HB1313 Detail]
Download: Texas-2023-HB1313-Introduced.html
| By: Burrows | H.B. No. 1313 | |
|
|
||
|
|
||
| relating to a study on the side effects, adverse reactions, | ||
| including death, and the effectiveness of vaccines against the | ||
| SARS-CoV-2 virus (COVID-19) or its variants. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. (a) In this section: | ||
| (1) "Commission" means the Health and Human Services | ||
| Commission. | ||
| (2) "Executive commissioner" means the executive | ||
| commissioner of the Health and Human Services Commission. | ||
| (3) "Department" means the Department of State Health | ||
| Services. | ||
| (4) "COVID 19" means the SARS-CoV-2 virus and any of | ||
| its variants. | ||
| (5) "Vaccine" means a substance used to stimulate | ||
| immunity to a particular infectious disease or pathogen, typically | ||
| prepared from an inactivated or weakened form of the causative | ||
| agent or from its constituents or products. | ||
| (b) The Commission in collaboration with the Department | ||
| shall conduct a study to assess the full and complete adverse | ||
| reactions, including death, and effectiveness of each type of | ||
| vaccine used in Texas to defend the human body against "COVID 19. | ||
| The Report must include: | ||
| (1) The immediate short-term side effects and adverse | ||
| reactions recipients experienced from taking the various Covid-19 | ||
| vaccines used in Texas; including but not limited to include: | ||
| i. Pain, swelling, or redness where the shot was | ||
| given | ||
| ii. Mild fever | ||
| iii. Chills | ||
| iv. Feeling tired | ||
| v. Headache | ||
| vi. Muscle and joint aches | ||
| (2) The immediate serious side effects and adverse | ||
| reactions recipients experienced from taking the various Covid-19 | ||
| vaccines used in Texas; including but not limited to include: | ||
| i. difficulty breathing; | ||
| ii. swelling of the face and throat; | ||
| iii. accelerated heartbeat; | ||
| iv. a body rash; | ||
| v. dizziness; and | ||
| vi. weakness | ||
| (3) Any long-term side effects and adverse reactions | ||
| recipients have experienced from taking the various Covid-19 | ||
| vaccines used in Texas; including but not limited to include: | ||
| i. paralysis; | ||
| ii. Myocarditis; | ||
| iii. clotting disorders; | ||
| iv. Thrombosis with Thrombocytopenia Syndrome | ||
| (TTS); | ||
| v. Guillain-Barré syndrome (GBS); | ||
| vi. difficulty thinking or "brain fog," | ||
| vii. chronic pain; | ||
| viii. tiredness and fatigue; | ||
| ix. loss of taste; | ||
| x. depression; | ||
| xi. anxiety; and | ||
| xii. death. | ||
| (4) Any misrepresentations about the effectiveness or | ||
| dangers of taking of the vaccine by its manufacturers or any | ||
| governmental agency; and, | ||
| (5) Any concealment of information about the | ||
| effectiveness or dangers of taking of the vaccine by its | ||
| manufacturers or any governmental agency. | ||
| (c) The Commission and the Department shall gather | ||
| information for the report from: | ||
| (1) information collected by the Commission and the | ||
| Department, including information from the department's vital | ||
| statistics unit and the state Medicaid program; and | ||
| (2) hospitals, treatment centers, available surveys, | ||
| (3) and other relevant sources. | ||
| SECTION 2. (a) Not later than January 1, 2024, the | ||
| Commission and Department shall prepare and submit to the Governor, | ||
| Lieutenant Governor, the Speaker of the House of Representatives, | ||
| and the Chairpersons of the relevant Texas legislative committees | ||
| with jurisdiction over the Commission and the Department, a copy of | ||
| the report, summary of any findings, and any recommendations for | ||
| legislative or executive action to reduce the prevalence of | ||
| COVID-19 Vaccine side effects. The department may post the report | ||
| on the department's Internet website. | ||
| (b) The Commission and Department may accept gifts, grants, | ||
| and donations from any source to fund expenses incurred by the | ||
| Commission and the Department in preparing the report. | ||
| SECTION 3. This Act expires September 1, 2025. | ||
| SECTION 4. This Act takes effect immediately if it receives | ||
| a vote of two-thirds of all the members elected to each house, as | ||
| provided by Section 39, Article III, Texas Constitution. If this | ||
| Act does not receive the vote necessary for immediate effect, this | ||
| Act takes effect September 1, 2023. | ||
